Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Long-Term (â‰¥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma
